Alternatively, if the CD5low CLL B-cell population is hierarchically below the CD5high CLL B-cell population (i.e., closer to differentiation and/or apoptosis), then understanding how CD5 expression can become downregulated may represent a therapeutic approach. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.